Product Information
VERAPAMIL ER 120 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.1905 per EA under NDC 75834032001. Its NADAC has been published 159 times since Jun 14, 2023.
Strength
120 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834032001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VERAPAMIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206173On Market Since
1/2/2023
Pharmacological Classes
Price Statistics
The NADAC for VERAPAMIL ER 120 MG TABLET has been published 159 times since Jun 14, 2023, and over the history we have for it it has declined 22.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1905 per EA |
|---|---|
| All-time high | $0.2665 (Dec 13, 2023) |
| All-time low | $0.1801 (May 22, 2024) |
| 52-week high | $0.2492 |
| 52-week low | $0.1905 |
| Median price | $0.2220 |
| Average price | $0.2211 |
| Largest weekly change | +29.2% (Feb 21, 2024) |
| Weeks tracked | 159 |
| Tracking since | Jun 14, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 55% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VERAPAMIL ER 120 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL ER 120 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.1905 per EA (NDC 75834032001), effective Jun 24, 2026.
How has the price of VERAPAMIL ER 120 MG TABLET changed over time?
Over the history we have for it, the NADAC for VERAPAMIL ER 120 MG TABLET has declined 22.6%. It has been tracked across 159 weekly CMS publications since Jun 14, 2023.
What are the highest and lowest recorded NADAC prices for VERAPAMIL ER 120 MG TABLET?
Since Jun 14, 2023, the NADAC for VERAPAMIL ER 120 MG TABLET has ranged from a low of $0.1801 (May 22, 2024) to a high of $0.2665 (Dec 13, 2023), with a median of $0.2220 per EA.
Are there cheaper alternatives to VERAPAMIL ER 120 MG TABLET?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, VERAPAMIL 120 MG TABLET, is $0.0858 per EA — about 55% below VERAPAMIL ER 120 MG TABLET.
Who manufactures VERAPAMIL ER 120 MG TABLET?
VERAPAMIL ER 120 MG TABLET (NDC 75834032001) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification